Back to Agenda
Collaborative Frameworks and Public Private Partnerships as Drivers of Innovation
Session Chair(s)
Corinne de Vries, PHD, MA, MSC
EMA liaison official to the US FDA, European Medicines Agency, Netherlands
A condensed overview of the current state of play when it comes to PPP s from an EU perspective and their key role in bringing together the latest research and cutting-edge technology to boost innovation and entrepreneurship in the pharmaceutical sector, to meet the challenges faced by patients and society as a whole.
Speaker(s)
Pierre Meulien, PHD
Executive Director, Innovative Medicines Initiative (IMI), Belgium
Accelerating Innovation through Public Private Partnerships: IMI as an Example
Martha Ann Brumfield, PHD
President and Chief Executive Officer, Critical Path Institute, United States
Advancing Innovation with Novel Methodologies - C-Path’s PPP Approach to Achieving Regulatory Acceptance
Gerd Kullak-Ublick
Global Head, Mechanistic Safety, Chief Medical Office and Patient Safety, Novartis, Switzerland
The IMI SAFE-T Consortium: Engaging with Regulators to Enhance Success and Opportunities of Public Private Partnerships
Have an account?